BKYI BIO KEY INTERNATIONAL INC: institutional ownership and insider trading
1 funds reported holding $18.8K of BIO KEY INTERNATIONAL INC in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 9 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $6.70M and net income of $8.28M.
BKYI revenue and earnings
- Quarter ended Jun 30, 2026: revenue $1.92M, net income −$577K
- Quarter ended Mar 31, 2026: revenue $2.15M, net income −$205K
- Quarter ended Dec 31, 2025: revenue $1.08M, net income $10.0M
- Quarter ended Sep 30, 2025: revenue $1.55M, net income −$965K
Largest institutional holders of BKYI
- VANGUARD GROUP INC — $18.8K
Recent BKYI insider trades
- Sep 16, 2025: Depasquale Michael W bought 4,117 shares ($3.23K)
- Aug 22, 2025: Sullivan James David bought 10,000 shares ($7.70K)
- Jun 13, 2025: Depasquale Michael W bought 5,000 shares ($3.90K)
- Jun 3, 2025: Depasquale Michael W bought 4,000 shares ($3.32K)
Who owns the most BKYI stock?
The largest institutional holders of BIO KEY INTERNATIONAL INC in the latest 13F filings are VANGUARD GROUP INC ($18.8K).
Are insiders buying or selling BKYI?
No open-market insider buys or sells of BIO KEY INTERNATIONAL INC were reported in the last 12 months.
What was BKYI's revenue last quarter?
BIO KEY INTERNATIONAL INC reported revenue of $1.92M for the quarter ended June 30, 2026, with net income of −$577K.